Has Cyndi Torosky Tommaso, MD received payments from drug or device companies?

Yes. Drug and device makers reported $716,746 in general payments to Cyndi Torosky Tommaso, MD across 1,689 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cyndi Torosky Tommaso, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cyndi Torosky Tommaso, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cyndi Torosky Tommaso, MD

Dermatology · Virginia Beach, VANPI 1679759807

Payments from drug & device makers

$716,746in general payments, 2019–2025

Across 1,689 payments — averaging $424.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$302K
Galderma Laboratories, L.p.$150K
Amgen$106K
Janssen Scientific Affairs, LLC$56K
Johnson & Johnson$47K
VYNE Pharmaceuticals Inc.$20K
plus $36K from 42 others

What the payments were for

Consulting fees$13,1082%
Speaking & faculty fees$624,82487%
Travel & lodging$39,9326%
Food & beverage$38,4245%
Education$4590%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	523	$301,999
Galderma Laboratories, L.p.	259	$150,407
Amgen	136	$106,100
Janssen Scientific Affairs, LLC	41	$55,633
Johnson & Johnson	112	$46,987
VYNE Pharmaceuticals Inc.	28	$19,581
UCB, Inc.	79	$10,766
Bristol Myers Squibb	15	$8,988
LEO Pharma Inc.	71	$4,336
Aclaris Therapeutics, Inc.	5	$2,661
Lilly USA, LLC	53	$1,073
Almirall LLC	4	$848
Novartis	29	$755
Sun Pharmaceutical Industries Inc.	38	$740
Arcutis Biotherapeutics, Inc.	43	$732
Sanofi	55	$707
Pfizer	40	$687
E.r. Squibb & Sons, L.L.C.	25	$535
Incyte Corporation	17	$436
Merz North America, Inc.	3	$410
Biofrontera Inc.	12	$311
Regeneron Healthcare Solutions, Inc.	14	$306
Boehringer Ingelheim	8	$217
Helsinn Therapeutics (U.S.), Inc.	10	$160
Sanofi-aventis U.S. LLC	3	$155
EPI Health, LLC	7	$139
Organon	6	$135
Kyowa Kirin, Inc.	6	$114
Merck	5	$89
Dermira, Inc.	5	$88
Ortho Dermatologics, A Division Of Bausch Health US, LLC	5	$86
Dermavant Sciences, Inc.	3	$64
Mayne Pharma Commercial LLC	3	$60
Revance Therapeutics, Inc.	2	$57
Verrica Pharmaceuticals Inc.	2	$44
Strata Skin Sciences, Inc.	3	$39
Blueprint Medicines Corporation	2	$38
DUSA Pharmaceuticals, Inc.	2	$37
Taro Pharmaceuticals USA, Inc.	2	$31
Genentech USA, Inc.	2	$30
Springworks Therapeutics, Inc.	1	$30
Glenmark Therapeutics Inc.	2	$29
Mylan Pharmaceuticals Inc.	2	$27
Biocon Biologics Inc	1	$20
Sandoz	1	$18
Hill Dermaceuticals, Inc.	2	$18
Fresenius Kabi USA, LLC	1	$14
Stemline Therapeutics Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$142,581
Otezla$103,473
Tremfya$100,479
Humira$80,808
AKLIEF$67,075
Rinvoq$46,669
TWYNEO$45,873
EPSOLAY$41,223
ORACEA$26,773
NEMLUVIO$18,981
AMZEEQ$10,511
ZILXI$8,614
Bimzelx$7,679
ADBRY$3,124
EPIDUO FORTE$2,700
Rhofade$2,623
DYSPORT$2,250
Klisyri$800
EBGLYSS$124
COSENTYX$116

How this compares

$716,746 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia →

Medicare billing

Part B allowed, 2024

$348,610

Medicare patients

982

Services billed

9,570

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Taltz AutoinjectorIxekizumab	12	$79,968
Ketoconazole	302	$5,990
Clobetasol Propionate	59	$3,705
Fluorouracil	31	$2,475
Clindamycin Phosphate	25	$2,126
Metronidazole	35	$1,961
Ammonium Lactate	65	$1,487
Triamcinolone Acetonide	112	$1,164
Doxycycline Hyclate	42	$871
ValacyclovirValacyclovir Hcl	46	$663
Dutasteride	19	$522
Hydroxychloroquine Sulfate	12	$465
Finasteride	16	$220
Minocycline Hcl	13	$193
Mupirocin	20	$176

Paid to pharmacies, not to this prescriber.

Other dermatology in Virginia Beach

Diego DasilvaVirginia Beach$1.1M
Tara Buehler BotaVirginia Beach$21K
David PariserNorfolk$7M
Jennifer DesimoneFairfax$2.3M
Naiem IssaVienna$2M
Saurabh SinghFairfax$1.7M
Vishal PatelLeesburg$1.1M
Carrie CobbLynchburg$859K
Yvonne KnightRichmond$857K
David BrayAlexandria$799K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →